Warwick Lamb, Managing Director of Imugene. “The gene used is the correct protective gene and once we get correct expression of this gene, we expect effective protection against the Avian Influenza.” “Reconstruction of a new batch of the vaccine will soon commence and trials are expected to be underway early in 2005. The new batch will be tested at several stages to ensure that the defect has been corrected. This will ensure that the protective gene will express as expected,” said Dr Lamb.
Warwick Lamb, Managing Director of Imugene. “The gene used is...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.8¢ |
Change
0.006(9.68%) |
Mkt cap ! $499.7M | |||
| Open | High | Low | Value | Volume |
| 7.3¢ | 8.1¢ | 6.7¢ | $14.56M | 194.2M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 605784 | 6.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 159880 | 2 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |